COVID-19: Merck Seeks FDA Emergency Use Authorisation for Antiviral Pill
Merck seeks FDA emergency use authorization for antiviral pill treatment molnupiravir for COVID-19. Merck has been producing molnupiravir at risk and expects to produce 10 million courses of treatment by the end of 2021. Ekohotblog reports that pharmaceutical giant, Merck, known as MSD outside the US and Canada, and Ridgeback Biotherapeutics, said Monday, October 11, … Read more